Atlas Trials

The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates

Clinical trial NCT00722722 · COMPLETED

Trial details

NCT number
NCT00722722
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Transplantation
Start date
2008-06-01
Primary completion
2014-04-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.